ROKIT HEALTHCARE Inc. Seeks to Acquire Inopia Tech, a Company Under Reorganization, for 7 billion won
Plans to Acquire 100% Stake Through Participation in a Third-Party Private Placement
INNOTECH Co.,Ltd Reports 26.1 Billion Won Net Loss Last Year and Receives an Adverse Audit Opinion
Company to Use Part of the Proceeds from the Existing 30 billion won Convertible Bond Issuance for the Acquisition
[Edaily Reporter KIM SAE-MI ] #ROKIT HEALTHCARE Inc. is set to acquire Inopia Tech, which is currently undergoing rehabilitation proceedings, for 7 billion won to secure management control.
ROKIT HEALTHCARE Inc. CI (Photo: ROKIT HEALTHCARE Inc.) ROKIT HEALTHCARE Inc. announced on the 16th that it has decided to acquire 1.4 million new shares of INNOTECH Co.,Ltd for 7 billion won. The acquisition amount represents 16.65% of its equity. Following the acquisition, ROKIT HEALTHCARE Inc. will hold a 100% stake, and the scheduled completion date is March 31 of next year.
This transaction will take place through participation in a third-party private placement under INNOTECH Co.,Ltd’s reorganization plan. ROKIT HEALTHCARE Inc. stated that the purpose of the acquisition is to strengthen business capabilities and create synergies by securing management control.
Inopia Tech is a company that develops and supplies embedded systems, such as set-top boxes and Internet of Things (IoT) gateways. Last year, it recorded revenue of 23.8 billion won and a net loss of 26.1 billion won. As of the end of last year, its total capital stood at -24.5 billion won, indicating a state of complete capital impairment, and the company received a disclaimer of opinion from its external auditor.
Previously, on July 30 of last year, ROKIT HEALTHCARE Inc. issued its 9th series of convertible bonds (CB) worth 30 billion won, allocating 8 billion won of those funds for the acquisition of securities in other companies. The company announced today via a corrected disclosure that INNOTECH Co.,Ltd had been confirmed as the investment target for those funds.
A ROKIT HEALTHCARE Inc. official stated, “This investment agreement is subject to the approval of the competent rehabilitation court to take effect, and if court approval is not granted, the transaction may be withdrawn or terminated in accordance with the procedures stipulated in the agreement.” The official added, “Whether the transaction proceeds and the scheduled acquisition date may change depending on whether the contractual preconditions—such as the passage of the rehabilitation plan and court approval—are met.”
Domestic bond market experts have named the chemical industry as the sector expected to face deteriorating business conditions within the next year for the third consecutive year. Market concerns show…
OTOKI has succeeded in increasing its revenue, driven by strong sales of instant noodles and sauces and rapid overseas growth, despite deteriorating profitability in the domestic market.Ottogi(007310)…
Rainbow Robotics(277810)reported a widening net loss in the third quarter of this year despite revenue growth. While sales to its largest shareholder, SamsungElectronics, increased, the proportion of …